Is piperacillin/tazobactam an effective carbapenem alternative to treat bloodstream infections caused by ESBL-producing enterobacteriaceae.
Leonor Rojas, PharmD, BCPS, BCIDP
Advertisement
Articles by Leonor Rojas, PharmD, BCPS, BCIDP
Advertisement
Latest Updated Articles
What Are the Implications of the MERINO Trial?Published: January 24th 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Expands Approval of Sotatercept-csrk for Pulmonary Arterial Hypertension
2
States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments
3
Expert Insights on Key Data from IMS 2025
4
Clinical Data Support Use of Low-Carbon Version of Albuterol Metered Dose Inhaler for Asthma
5
